International Clinical Trial: A single center, prospective, randomized controlled cohort study to explore the efficacy and safety of early and sufficient simplified N-acetylcysteine combined with Lee's artificial liver in the treatment of hepatitis B liver failure

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123231) titled 'A single center, prospective, randomized controlled cohort study to explore the efficacy and safety of early and sufficient simplified N-acetylcysteine combined with Lee's artificial liver in the treatment of hepatitis B liver failure' on April 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shulan (Hangzhou) hospital

Condition: Liver failure

Intervention: Standard Treatment Group:Li's artificial liver support combined with N-acetylcysteine (NAC) standard dosing regimen (loading dose: D1 8g infused over 1h 2g infused over 4h 6g infused over 16h D2 4g q12h D3 4g q12h) Simplified R...